![glp 1 analogue List of current GLP-1 and its analogs [36-39] Frontiers | GLP-1 Receptor Agonists:](https://www.researchgate.net/publication/371322849/figure/tbl1/AS:11431281165596278@1686056417230/List-of-current-GLP-1-and-its-analogs-36-39.png)
glp 1 analogue List of current GLP-1 and its analogs [36-39] Frontiers | GLP-1 Receptor Agonists:
Description
Does Kaiser cover Mounjaro
![glp 1 analogue List of current GLP-1 and its analogs [36-39] Frontiers | GLP-1 Receptor Agonists:](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/721135/fendo-12-721135-HTML/image_m/fendo-12-721135-g001.jpg)
British national formulary: BNF 76 (76 ed.)
![glp 1 analogue List of current GLP-1 and its analogs [36-39] Frontiers | GLP-1 Receptor Agonists:](https://family-medicine.org/wp-content/uploads/2024/04/GLP_1_weight_loss_regain-1-1024x607.png)
M., Kopec, J
![glp 1 analogue List of current GLP-1 and its analogs [36-39] Frontiers | GLP-1 Receptor Agonists:](https://guides.secondnature.io/wp-content/uploads/2023/11/GLP-1hormone.png)
In contrast to GIP, GLP-1 was found to retain its insulinotropic effect in patients, and this fact provides part of the background for the clinical use of GLP-1 receptor agonists in diabetes treatment
![glp 1 analogue List of current GLP-1 and its analogs [36-39] Frontiers | GLP-1 Receptor Agonists:](https://www.apexanesthesia.com/wp-content/uploads/2024/05/article_GLP1_organ_effects.jpg)
The prior authorization process for GLP-1s averages 2 to 6 weeks, with initial denial rates for weight loss use hitting 30% to 50%
![glp 1 analogue List of current GLP-1 and its analogs [36-39] Frontiers | GLP-1 Receptor Agonists:](https://www.polarismarketresearch.com/assets/images/media/glp-1-analogues-market-segment.png)
